Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

Dumoutier, 2000, Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9, J Immunol, 164, 1814, 10.4049/jimmunol.164.4.1814

Dumoutier, 2000, Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor, Proc Natl Acad Sci USA, 97, 10144, 10.1073/pnas.170291697

Xie, 2000, Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R, J Biol Chem, 275, 31335, 10.1074/jbc.M005304200

Blumberg, 2001, Interleukin 20: discovery, receptor identification, and role in epidermal function, Cell, 104, 9, 10.1016/S0092-8674(01)00187-8

Gallagher, 2000, Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10), Genes Immun, 1, 442, 10.1038/sj.gene.6363714

Knappe, 2000, Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri, J Virol, 74, 3881, 10.1128/JVI.74.8.3881-3887.2000

Jiang, 1995, Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression, Oncogene, 11, 2477

Volk, 2001, IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets, Trends Immunol, 22, 414, 10.1016/S1471-4906(01)01985-8

Kotenko, 2003, IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex, Nat Immunol, 4, 69, 10.1038/ni875

Sheppard, 2003, IL-28, IL-29 and their class II cytokine receptor IL-28R, Nat Immunol, 4, 63, 10.1038/ni873

Donnelly, 2004, The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain, J Leukoc Biol, 76, 314, 10.1189/jlb.0204117

Langer, 2004, The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions, Cytokine Growth Factor Rev, 15, 33, 10.1016/j.cytogfr.2003.10.001

Pestka, 2004, Interleukin-10 and related cytokines and receptors, Annu Rev Immunol, 22, 929, 10.1146/annurev.immunol.22.012703.104622

Logsdon, 2002, Comparison of interleukin-22 and interleukin-10 soluble receptor complexes, J Interferon Cytokine Res, 22, 1099, 10.1089/10799900260442520

Reineke, 1999, Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope, J Mol Recognit, 12, 242, 10.1002/(SICI)1099-1352(199907/08)12:4<242::AID-JMR461>3.0.CO;2-1

Dumoutier, 2000, IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes, Genes Immun, 1, 488, 10.1038/sj.gene.6363716

Kotenko, 2002, The family of IL-10-related cytokines and their receptors: related, but to what extent?, Cytokine Growth Factor Rev, 13, 223, 10.1016/S1359-6101(02)00012-6

Nagem, 2002, Crystal structure of recombinant human interleukin-22, Structure (Camb), 10, 1051, 10.1016/S0969-2126(02)00797-9

Xu, 2005, Structure of insect-cell-derived IL-22, Acta Crystallogr D Biol Crystallogr, 61, 942, 10.1107/S0907444905009601

Chang, 2003, Crystal structure of interleukin-19 defines a new subfamily of helical cytokines, J Biol Chem, 278, 3308, 10.1074/jbc.M208602200

Walter, 1995, Crystal structure of interleukin 10 reveals an interferon gamma-like fold, Biochemistry, 34, 12118, 10.1021/bi00038a004

Zdanov, 1995, Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma, Structure, 3, 591, 10.1016/S0969-2126(01)00193-9

Kotenko, 2001, Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes, J Biol Chem, 276, 2725, 10.1074/jbc.M007837200

Logsdon, 2004, The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation, J Mol Biol, 342, 503, 10.1016/j.jmb.2004.07.069

Wolk, 2002, Cutting edge: immune cells as sources and targets of the IL-10 family members?, J Immunol, 168, 5397, 10.4049/jimmunol.168.11.5397

Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007

Wolk, 2006, IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis, Eur J Immunol, 36, 1309, 10.1002/eji.200535503

Wolk, 2005, Is there an interaction between interleukin-10 and interleukin-22?, Genes Immun, 6, 8, 10.1038/sj.gene.6364144

Leung, 2003, Atopic dermatitis, Lancet, 361, 151, 10.1016/S0140-6736(03)12193-9

Andoh, 2005, Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts, Gastroenterology, 129, 969, 10.1053/j.gastro.2005.06.071

Ikeuchi, 2005, Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine, Arthritis Rheum, 52, 1037, 10.1002/art.20965

Whittington, 2004, Interleukin-22: a potential immunomodulatory molecule in the lung, Am J Respir Cell Mol Biol, 31, 220, 10.1165/rcmb.2003-0285OC

Kotenko, 1997, Identification and functional characterization of a second chain of the interleukin-10 receptor complex, EMBO J, 16, 5894, 10.1093/emboj/16.19.5894

Adams RL, Farrah TM, Jelmberg AC, Lok S, Whitemore TE, Patent WO9907848-A1 and U.S. Patent 5,965,704; 1999.

Tachiiri, 2003, Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice, Genes Immun, 4, 153, 10.1038/sj.gene.6363934

Li, 2004, Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2, Int Immunopharmacol, 4, 693, 10.1016/j.intimp.2004.01.010

Josephson, 2001, Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site, Immunity, 15, 35, 10.1016/S1074-7613(01)00169-8

Reineke, 1998, Mapping of the interleukin-10/interleukin-10 receptor combining site, Protein Sci, 7, 951, 10.1002/pro.5560070412

Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J Immunol, 174, 3695, 10.4049/jimmunol.174.6.3695

Lecart, 2002, IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells, Int Immunol, 14, 1351, 10.1093/intimm/dxf096

Aggarwal, 2001, Acinar cells of the pancreas are a target of interleukin-22, J Interferon Cytokine Res, 21, 1047, 10.1089/107999001317205178

Parrish-Novak, 2002, Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions, J Biol Chem, 277, 47517, 10.1074/jbc.M205114200

Dumoutier, 2001, Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22, J Immunol, 166, 7090, 10.4049/jimmunol.166.12.7090

Gruenberg, 2001, A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta, Genes Immun, 2, 329, 10.1038/sj.gene.6363786

Kotenko, 2001, Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity, J Immunol, 166, 7096, 10.4049/jimmunol.166.12.7096

Wei, 2003, Cloning and characterization of mouse IL-22 binding protein, Genes Immun, 4, 204, 10.1038/sj.gene.6363947

Weiss, 2004, Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart, Genes Immun, 5, 330, 10.1038/sj.gene.6364104

Xu, 2001, A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist, Proc Natl Acad Sci USA, 98, 9511, 10.1073/pnas.171303198

Dumoutier, 2001, Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types, J Immunol, 167, 3545, 10.4049/jimmunol.167.7.3545

Lejeune, 2002, Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, J Biol Chem, 277, 33676, 10.1074/jbc.M204204200

Oral, 2006, Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26, Eur J Immunol, 36, 380, 10.1002/eji.200425523

Salazar, 2001, Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders, Eur J Clin Invest, 31, 1070, 10.1046/j.1365-2362.2001.00913.x

Radaeva, 2004, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 39, 1332, 10.1002/hep.20184

Pan, 2004, Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3, Cell Mol Immunol, 1, 43

Schroder, 2006, Antimicrobial skin peptides and proteins, Cell Mol Life Sci, 63, 469, 10.1007/s00018-005-5364-0

Powell, 1999, Myofibroblasts. II. Intestinal subepithelial myofibroblasts, Am J Physiol, 277, 10.1152/ajpcell.1999.277.2.C183

Dohi, 2005, Therapeutic potential of follistatin for colonic inflammation in mice, Gastroenterology, 128, 411, 10.1053/j.gastro.2004.11.063

Hubner, 1997, Activin A: a novel player and inflammatory marker in inflammatory bowel disease?, Lab Invest, 77, 311

Grosfeld, 1999, Interleukin-11: its biology and prospects for clinical use, JPEN J Parenter Enteral Nutr, 23, S67, 10.1177/014860719902300517

Murphy, 1998, Growth factors and the gastrointestinal tract, Nutrition, 14, 771, 10.1016/S0899-9007(98)00081-1

Kalabis, 2003, Stimulation of human colonic epithelial cells by leukemia inhibitory factor is dependent on collagen-embedded fibroblasts in organotypic culture, FASEB J, 17, 1115, 10.1096/fj.02-0852fje

Nagakawa, 2004, Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts, Scand J Immunol, 60, 449, 10.1111/j.0300-9475.2004.01504.x